Increased c-MET and TGF-β pathway activity may promote tumor progression in glioblastoma via invasion, migration, angiogenesis, cell survival, SC maintenance, and immune evasion13,23–28, however, their potential interactions may not have been sufficiently studied. The gene discussed is MET; the disease is glioblastoma.